Clinical Trial Update: PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cromolyn (PHENOGENE-1A) for amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Cromolyn (cromolyn sodium)

Snippet

Sponsor: PhenoNet, Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: RECRUITING